Norges Bank’s Gilead Sciences GILD Stock Holding History

Norges Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,322,732	Closed	-$2.62B	–	566
2025 Q4	$2.62B	Buy	+21,322,732	New	+$2.59B	0.28%	58
2025 Q3	–	Sell	-19,394,502	Closed	-$2.15B	–	633
2025 Q2	$2.15B	Sell	19,394,502 -461,308	-2%	-$49.1M	0.27%	67
2025 Q1	$2.22B	Buy	19,855,810 +485,300	+3%	+$50.1M	0.31%	52
2024 Q4	$1.79B	Buy	19,370,510 +1,667,244	+9%	+$150M	0.23%	70
2024 Q3	$1.48B	Buy	17,703,266 +314,209	+2%	+$24M	0.21%	90
2024 Q2	$1.19B	Buy	17,389,057 +129,057	+0.7%	+$8.61M	0.18%	103
2024 Q1	$1.26B	Buy	17,260,000 +1,192,555	+7%	+$91.7M	0.2%	94
2023 Q4	$1.3B	Buy	16,067,445 +1,392,910	+9%	+$108M	0.23%	80
2023 Q3	$1.1B	Buy	14,674,535 +176,438	+1%	+$13.6M	0.22%	87
2023 Q2	$1.12B	Buy	14,498,097 +368,240	+3%	+$29.4M	0.22%	86
2023 Q1	$1.17B	Buy	14,129,857 +1,139,918	+9%	+$94.4M	0.26%	73
2022 Q4	$1.12B	Sell	12,989,939 -135,591	-1%	-$10.7M	0.27%	73
2022 Q3	$810M	Buy	13,125,530 +827,464	+7%	+$52.2M	0.22%	89
2022 Q2	$760M	Sell	12,298,066 -79,614	-0.6%	-$4.93M	0.2%	95
2022 Q1	$736M	Sell	12,377,680 -718,461	-5%	-$45.9M	0.16%	117
2021 Q4	$951M	Sell	13,096,141 -54,525	-0.4%	-$3.76M	0.2%	100
2021 Q3	$919M	Sell	13,150,666 -150,781	-1%	-$10.6M	0.2%	95
2021 Q2	$916M	Sell	13,301,447 -519,026	-4%	-$34.7M	0.2%	92
2021 Q1	$893M	Buy	13,820,473 +645,946	+5%	+$41.7M	0.2%	89
2020 Q4	$768M	Sell	13,174,527 -67,468	-0.5%	-$4.07M	0.18%	99
2020 Q3	$837M	Buy	13,241,995 +314,866	+2%	+$21.8M	0.22%	78
2020 Q2	$995M	Sell	12,927,129 -1,259,512	-9%	-$96.5M	0.29%	66
2020 Q1	$1.06B	Buy	14,186,641 +957,928	+7%	+$66.2M	0.38%	52
2019 Q4	$860M	Sell	13,228,713 -258,000	-2%	-$16.8M	0.24%	75
2019 Q3	$855M	Buy	13,486,713 +74,096	+0.6%	+$4.84M	0.26%	71
2019 Q2	$906M	Buy	13,412,617 +181,374	+1%	+$11.9M	0.28%	66
2019 Q1	$860M	Buy	13,231,243 +459,358	+4%	+$30.5M	0.28%	67
2018 Q4	$799M	Buy	12,771,885 +128,964	+1%	+$9.01M	0.3%	65
2018 Q3	$976M	Hold	12,642,921	–	–	0.32%	58
2018 Q2	$896M	Sell	12,642,921 -190,951	-1%	-$13.5M	0.31%	62
2018 Q1	$968M	Buy	12,833,872 +294,495	+2%	+$23.4M	0.35%	53
2017 Q4	$898M	Hold	12,539,377	–	–	0.32%	54
2017 Q3	$1.02B	Buy	12,539,377 +163,079	+1%	+$12.5M	0.39%	44
2017 Q2	$876M	Sell	12,376,298 -922,350	-7%	-$61.4M	0.35%	50
2017 Q1	$903M	Sell	13,298,648 -624,660	-4%	-$43.9M	0.37%	46
2016 Q4	$997M	Buy	13,923,308 +137,881	+1%	+$10.2M	0.44%	39
2016 Q3	$1.04B	Buy	13,785,427 +194,177	+1%	+$15.8M	0.49%	38
2016 Q2	$1.13B	Buy	13,591,250 +895,278	+7%	+$79.5M	0.54%	35
2016 Q1	$1.17B	Sell	12,695,972 -232,322	-2%	-$21M	0.57%	33
2015 Q4	$1.31B	Buy	12,928,294 +436,388	+3%	+$45.4M	0.65%	31
2015 Q3	$1.23B	Buy	12,491,906 +599,337	+5%	+$66.6M	0.64%	29
2015 Q2	$1.39B	Buy	11,892,569 +48,699	+0.4%	+$5.32M	0.7%	24
2015 Q1	$1.16B	Buy	11,843,870 +53,104	+0.5%	+$5.39M	0.57%	32
2014 Q4	$1.11B	Buy	11,790,766 +629,423	+6%	+$65.1M	0.56%	31
2014 Q3	$1.19B	Sell	11,161,343 -9,292,295	-45%	-$910M	0.64%	24
2014 Q2	$1.7B	Buy	20,453,638 +10,026,944	+96%	+$780M	0.46%	38
2014 Q1	$739M	Sell	10,426,694 -424,518	-4%	-$33.3M	0.42%	43
2013 Q4	$815M	Sell	10,851,212 -383,959	-3%	-$26.7M	0.47%	36
2013 Q3	$706M	Sell	11,235,171 -582,434	-5%	-$34.8M	0.41%	41
2013 Q2	$605M	Buy	+11,817,605	New	+$616M	0.38%	46

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank's GILD Position: Q1 2026 in Review

Norges Bank sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 21,322,732 shares — an estimated $2.62B sold.

Norges Bank first reported a position in GILD in Q2 2013 and held it in 50 quarters. The position peaked at $2.62B in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Norges Bank reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 21,322,732 Gilead Sciences shares in Q1 2026, an estimated $2.62B.
Norges Bank first reported a position in Gilead Sciences in Q2 2013 and held it in 50 quarters.
Norges Bank's Gilead Sciences position peaked at $2.62B in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.